Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What Are the Prospects for Inovio's COVID Vaccine?

TheMotleyFool

0 0

What Are the Prospects for Inovio's COVID Vaccine?

Inovio Pharmaceuticals (NASDAQ: INO) is one of several companies that lag behind the leaders in the COVID-19 vaccine race. The biotech is currently evaluating its COVID-19 vaccine candidate INO-4800 in a phase 2 study. In this Motley Fool Live video recorded on March 3, 2021, Fool.com contributors Keith Speights and Brian Orelli discuss what the prospects for Inovio's COVID vaccine might be.

Source Fool.com

Like: 0

INO

Share